343 Translational phase I trial combining the AKT inhibitor AZD5363 (AZD) and PARP inhibitor Olaparib (Ola) in advanced cancer patients (pts)
Michalarea, V, Lopez, J, Lorente, D, Carreira, S, Hassam, H, Parmar, M, Turner, A, Hall, E, Fandos, S. Serrano, Decordova, S, Swales, K, Ruddle, R, Raynaud, F, Tunariu, N, Stephens, C.M, Molife, L.R, Banerji, U, Plummer, R, Bono, J. De, Yap, T.A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article